share_log

Piper Sandler Maintains Overweight on Inspire Medical Systems, Raises Price Target to $255

Piper Sandler Maintains Overweight on Inspire Medical Systems, Raises Price Target to $255

派珀·桑德勒繼續增持Inspire Medical Systems,將目標股價上調至255美元
Benzinga ·  05/08 08:12

Piper Sandler analyst Adam Maeder maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and raises the price target from $250 to $255.

派珀·桑德勒分析師亞當·梅德維持增持Inspire Medical Systems(紐約證券交易所代碼:INSP),並將目標股價從250美元上調至255美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論